Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $43.1300 (0.14%) ($41.8100 - $43.1300) on Mon. Aug. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.62% (three month average) | RSI | 17 | Latest Price | $43.1300(0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.9% a day on average for past five trading days. | Weekly Trend | HALO declines -6.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(43%) IWM(36%) IWO(36%) IFRA(35%) IWN(35%) | Factors Impacting HALO price | HALO will decline at least -1.31% in a week (0% probabilities). VIXM(-14%) UUP(-8%) VXX(-6%) TBT(-5%) USO(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.31% (StdDev 2.62%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.65(-24.3%) | Resistance Level | $47.28 | 5 Day Moving Average | $43.37(-0.55%) | 10 Day Moving Average | $44.68(-3.47%) | 20 Day Moving Average | $47.28(-8.78%) | To recent high | -16.8% | To recent low | 3.7% | Market Cap | $5.895b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |